Instrument Inactif

Communiqués MusclePharm Corporation Other OTC

Actions

MSLP

US6273352012

Sociétés holdings

Communiqués

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
29/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
23/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
22/08/22	MUSCLEPHARM CORP : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ
17/08/22	MusclePharm : Late Filing Notice - Form NT 10-Q	PU
28/07/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
12/07/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
06/07/22	MusclePharm Announces the Launch of FitMiss Energy	AQ
22/06/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
14/06/22	MUSCLEPHARM CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
09/06/22	MUSCLEPHARM CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/06/22	MusclePharm Announces Private Placement of $2.5 Million Senior Secured Notes	AQ
24/05/22	MusclePharm to Present at the LD Micro Invitational XII Conference	AQ
16/05/22	MUSCLEPHARM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/05/22	MusclePharm Announces First Quarter 2022 Financial Results	AQ
10/05/22	MusclePharm to Announce First Quarter 2022 Financial Results on Monday, May 16, 2022	AQ
05/05/22	Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results	AQ
04/05/22	MUSCLEPHARM CORP - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
28/04/22	MusclePharm : Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021 - Form 8-K	PU
15/04/22	MUSCLEPHARM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
14/04/22	MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results	AQ
12/04/22	MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022	AQ
31/03/22	MusclePharm Announces Launch into Ready-to-Drink Protein Category	AQ